Alternative Data for Axogen
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 12 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 31,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 8,108 | Sign up | Sign up | Sign up |
| Instagram Followers | 2,427 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 10 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,403 | Sign up | Sign up | Sign up |
| X Followers | 921 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,190 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 33 | Sign up | Sign up | Sign up |
| Linkedin Employees | 596 | Sign up | Sign up | Sign up |
About Axogen
AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide.
| Price | $34.71 |
| Target Price | Sign up |
| Volume | 666,684 |
| Market Cap | $1.79B |
| Year Range | $13.9 - $35.38 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Earnings Date | April 28 '26 |
| Industry | Medical Devices |
In the news
What Makes Axogen (AXGN) an Investment Bet?April 2 - Yahoo Entertainment |
|
Axogen Q4: EPS Miss Amid Biologics TransitionFebruary 24 - SeekingAlpha |
|
HighMark Wealth Management Buys 158,855 Shares of Axogen StockFebruary 24 - Yahoo Entertainment |
|
 |
Axogen Inc (NASDAQ:AXGN) Reports Q4 2025 Revenue Growth but Misses Profit EstimatesFebruary 23 - ChartMill |
Axogen, Inc. (AXGN) Q4 2025 Earnings Call TranscriptFebruary 23 - SeekingAlpha |
|
Axogen, Inc. 2025 Q4 - Results - Earnings Call PresentationFebruary 23 - SeekingAlpha |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 60M | 14M | 46M | 710,000 | 13M | 0.120 |
| Q2 '25 | 57M | 15M | 42M | 580,000 | 4.4M | 0.120 |
| Q1 '25 | 49M | 14M | 35M | -3.8M | 300,000 | -0.020 |
| Q4 '24 | 49M | 12M | 38M | 450,000 | 4.2M | 0.070 |
| Q3 '24 | 49M | 12M | 36M | -1.9M | 2M | 0.070 |
Insider Transactions View All
| DeVinney Erick Wayne filed to sell 262,781 shares at $32.8. March 18 '26 |
| Wendell Amy McBride filed to sell 132,510 shares at $29.3. December 17 '25 |
| Weiler Kathy Johnson filed to sell 28,405 shares at $29.5. December 17 '25 |
| Weiler Kathy Johnson filed to sell 6,580 shares at $29.5. December 17 '25 |
Similar companies
Read more about Axogen (AXGN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Axogen
The Market Cap of Axogen is $1.79B.
Axogen will report its next earnings on April 28 '26.
Currently, the price of one share of Axogen stock is $34.71.
The AXGN stock price chart above provides a comprehensive visual representation of Axogen's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Axogen shares. Our platform offers an up-to-date AXGN stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Axogen (AXGN) does not offer dividends to its shareholders. Investors interested in Axogen should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Axogen are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
